paaH

Summary: Correct in branch but too general; the specific dehydrogenase activity is supported.

Reason: Q88HS1 is a 3-hydroxyacyl-CoA dehydrogenase-family protein (PROSITE 3HCDH signature; NCBIfam PaaH family TIGR02279), and its E. coli ortholog is an NAD+-dependent 3-hydroxyadipyl-CoA dehydrogenase. Refine to GO:0003857, which this gene already carries.

Proposed replacements: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity

Summary: Best available GO term for the assigned NAD-dependent reaction.

Reason: Q88HS1 carries the 3-hydroxyacyl-CoA dehydrogenase signature and NAD binding domain and is classified in the NCBIfam PaaH family. The E. coli ortholog was shown to act as an NAD+-dependent, probably (S)-specific, 3-hydroxyadipyl-CoA dehydrogenase; GO:0003857 is the most specific available term.

Summary: Broad family-level process annotation that obscures the paa pathway role.

Reason: The exact target is named 3-hydroxyadipyl-CoA dehydrogenase and is encoded in the phenylacetate catabolic locus, not a general fatty-acid metabolic enzyme. Its substrate, 3-hydroxyadipyl-CoA, is a dicarboxylic ring-cleavage product of phenylacetate rather than a fatty acyl-CoA. Marked over-annotated rather than removed because the dehydrogenase chemistry is shared with fatty-acid beta-oxidation enzymes of the same family.

Summary: Likely family-level over-annotation rather than the physiological pathway.

Reason: The rejection is retained on substrate grounds rather than on the propagation alone. GO:0006635 is defined as the process that "results in the complete oxidation of a long-chain fatty acid". The exact target is named 3-hydroxyadipyl-CoA dehydrogenase and sits in the paa locus, acting on the 3-hydroxy dicarboxylic CoA-ester produced after ring opening of phenylacetyl-CoA; adipyl-CoA is not a long-chain fatty acyl-CoA, and the gene's own GOA carries GO:0010124 phenylacetate catabolic process for the physiological pathway. Marked over-annotated rather than removed because the 3-hydroxyacyl-CoA dehydrogenase chemistry is genuinely shared with beta-oxidation and no assay excludes a minor fatty-acyl contribution.

Summary: Substrate-specific over-annotation from the broader enzyme family.

Reason: UniProt names the target 3-hydroxyadipyl-CoA dehydrogenase, not 3-hydroxybutyryl-CoA dehydrogenase. Activity on the shorter substrate has not been established for KT2440 PaaH. The PANTHER subfamily name (3-hydroxybutyryl-CoA dehydrogenase) reflects the dominant family member, whereas the NCBIfam PaaH family and the orthologous biochemistry point to 3-hydroxyadipyl-CoA.

Summary: Correct physiological pathway assignment.

Reason: PaaH is the NCBIfam PaaH-family 3-hydroxyacyl-CoA dehydrogenase encoded in the contiguous paa catabolic locus; its ortholog catalyzes the penultimate step of aerobic phenylacetate catabolism.

Summary: Correct parent activity but too general; the specific dehydrogenase term is supported.

Reason: Refine to the descendant GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity, which this gene already carries.

Proposed replacements: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity

Summary: Correct mechanistic parent but too general; the specific activity is supported.

Reason: Refine to the descendant GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity, which this gene already carries.

Proposed replacements: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity

Summary: Correct but unnecessarily broad process annotation.

Reason: Phenylacetate catabolic process (GO:0010124) is a descendant of monocarboxylic acid metabolic process and is the specific physiological role; this gene already carries it.

Proposed replacements: phenylacetate catabolic process

Summary: Plausible cofactor-binding property, but ancillary to the catalytic role.

Reason: Q88HS1 carries the 3-hydroxyacyl-CoA dehydrogenase NAD-binding domain and the E. coli ortholog is NAD+-dependent; binding alone is not the core biological function.